NASDAQ: MSPRMsp Recovery Inc Stock
$2.30-0.94 (-29.01%)
Updated Dec 9, 2024
MSPR Price
$2.30
Fair Value Price
N/A
Market Cap
$15.09M
52 Week Low
$1.43
52 Week High
$74.97
P/E
-0.02x
P/B
0.05x
P/S
2.21x
PEG
N/A
Dividend Yield
N/A
Revenue
$10.73M
Earnings
-$97.32M
Gross Margin
-4,443.2%
Operating Margin
2,740.41%
Profit Margin
-906.7%
Debt to Equity
6.46
Operating Cash Flow
-$26M
Beta
0.1
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
MSPR Overview
MSP Recovery, Inc. operates as a healthcare recoveries and data analytics company in the United States and Puerto Rico. The company offers claims recovery services, including services to related parties or third parties to assist entities with pursuit of claims recovery rights. It also provides Chase to pay service to assist its healthcare provider clients to identify in the first instance the proper primary insurer at the point of care and thereby avoid making a wrongful payment; and LifeWallet, a platform designed to locate and organize users' medical records. MSP Recovery, Inc. was founded in 2014 and is headquartered in Coral Gables, Florida.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MSPR's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
B
Value
A
Growth
D
Momentum
C
Sentiment
F
Safety
D
Financials
F
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
C
MSPR
Ranked#30 of 52
Ranked#30 of 52
Be the first to know about important MSPR news, forecast changes, insider trades & much more!
MSPR News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MSPR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MSPR is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MSPR is good value based on its book value relative to its share price (0.05x), compared to the US Health Information Services industry average (3.86x)
P/B vs Industry Valuation
MSPR is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more MSPR due diligence checks available for Premium users.
Valuation
MSPR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.02x
Industry
24.56x
Market
29.44x
MSPR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.05x
Industry
3.86x
MSPR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MSPR's financial health
Profit margin
Revenue
$3.7M
Net Income
-$29.8M
Profit Margin
-813.7%
MSPR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
MSPR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.8B
Liabilities
$1.9B
Debt to equity
6.46
MSPR's short-term liabilities ($1.21B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MSPR's long-term liabilities ($734.87M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MSPR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$6.7M
Investing
-$2.0M
Financing
$6.3M
MSPR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
MSPR vs Health Information Service Stocks
Msp Recovery Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.